Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
09/2000
09/26/2000US6124312 Heterocyclic compounds
09/26/2000US6124311 Administering oncolytic agent with enhanced multidrug resistance reversing amount of specified compound
09/26/2000US6124285 Indole-2,3-dione-3-oxime derivatives
09/26/2000US6124251 Toilet bowl cleaning tablet
09/26/2000US6124035 High temperature transfer molding resins
09/21/2000WO2000055144A1 Amine derivatives as protease inhibitors
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000055137A1 Compounds and methods for modulation of estrogen receptors
09/21/2000WO2000055134A1 Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
09/21/2000WO2000055133A1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000054759A2 Lxr modulators
09/21/2000DE19912638A1 Naphthylcarbonsäureamid-substituierte Sulfonamide Naphthylcarbonsäureamid-substituted sulfonamides
09/21/2000CA2368150A1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2367895A1 Compounds and methods for modulation of estrogen receptors
09/21/2000CA2367595A1 Lxr modulators
09/21/2000CA2367352A1 Amine derivatives as protease inhibitors
09/20/2000EP1036067A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
09/20/2000EP1036059A1 Adamantane derivatives
09/20/2000EP1036058A1 Adamantane derivatives
09/20/2000EP1035848A1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels
09/20/2000EP0932658B1 Asymmetrical imide bleach activators and compositions employing the same
09/20/2000CN1267281A Glucagon antagonists/inverse agonists
09/20/2000CN1056611C Pyrazolo and pyrrolopyridines, their use and intermidiates for preparing same
09/20/2000CN1056602C Esters and amides as PLAZ inhibitors
09/19/2000US6121460 Process for the preparation of an optically active indoline-2-carboxylic acid or derivative thereof
09/19/2000US6121325 Naphthyl compounds promote release of growth hormone
09/19/2000US6121307 Side effect reduction; administering to treat depression
09/19/2000US6121306 Resolving racemic mixture into (1s,4r)- and (1r,4s)-1-azabicyclo(2.2.1)heptan-3-one isomers by formation of di-p-toluoyl hemitartrate salts; storage stable form; use to prepare drugs such as muscarinic agonists
09/19/2000US6121304 Pentafluorobenzenesulfonamides and analogs
09/19/2000US6121292 Methods for reversing multidrug resistance
09/19/2000US6121281 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
09/19/2000US6121280 Azabicyclic rotomase inhibitors
09/19/2000US6121277 Antitumor agents
09/19/2000CA2107484C New arylalkyl(thio)amides, their preparation process and pharmaceutical compositions containing them
09/14/2000WO2000053608A1 Pyridopyranoazepine derivatives, preparation and therapeutic use
09/14/2000WO2000053573A1 Medicinal compositions with [2.2.1] and [3.1.1] bicycloskeleton antagonistic to both of pgd2/txa2 receptors
09/14/2000WO2000053313A2 Lanthanide catalysts for synthesis of compounds and combinatorial libraries
09/14/2000WO2000044722A8 Chondrongenesis promotors and indolin-2-one derivatives
09/14/2000WO2000031074A3 Indole derivatives and their use as serotonin receptor ligands
09/14/2000WO1999063999A8 H1-histamine receptor antagonists
09/13/2000EP1035114A2 Nitrogen-heterocyclic compounds and process for production thereof
09/13/2000EP1034221A1 Dibenzorhodamine dyes useful as fluorescent labelling agents
09/13/2000EP1034163A1 New cysteine derivatives, processes for their production, and pharmaceuticals containing them
09/13/2000EP1034162A1 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
09/13/2000EP0691962B1 1-amino-3-phenoxy propane derivatives as modulators of multi-drug resistance
09/13/2000CN1266057A Novel cyano-indole serotonin reextracted inhibitor compound, its preparation process and medicinal compositions having same
09/13/2000CN1056373C Process for preparation of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
09/12/2000US6118010 Catalytic reduction of the 1-alkoxycarbonyl-3-oxo-3-phenylpropyl derivative
09/12/2000US6118001 Anticancer agent; antiarthritic agent
09/12/2000US6117999 Chemical intermediate for nelfinavir
09/12/2000US6117893 Heterocyclic compounds having anti-diabetic activity and their use
09/12/2000US6117881 N-cinnamoyl derivatives of (β) carbolines
09/12/2000US6117822 Substituted phthalimidocinnamic acid derivatives and intermediates for their preparation
09/12/2000CA2047773C Derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation as well as the compositions containing them
09/08/2000WO2000052002A1 N-substituted imide derivatives with serotonergic activity
09/08/2000WO2000051984A1 2-aryl indole derivatives as antagonists of tachykinins
09/08/2000WO2000051983A1 N-SUBSTITUTED BENzOYL INDOLES AS ESTROGENIC AGENTS
09/08/2000WO2000051982A1 N-substituted indolines as estrogenic agents
09/08/2000WO2000051975A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors
09/08/2000WO2000051971A1 Oxamic acids and derivatives as thyroid receptor ligands
09/08/2000WO2000010526A3 New oral formulation for 5-ht4 agonists or antagonists
09/08/2000CA2364914A1 N-substituted benzoyl indoles as estrogenic agents
09/08/2000CA2364911A1 N-substituted indolines as estrogenic agents
09/08/2000CA2364878A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors
09/08/2000CA2361182A1 N-substituted imide derivatives with serotonergic activity
09/06/2000EP1032825A1 Improvements in or relating to electrochemical assays
09/06/2000EP1032631A2 O-substituted n,n-diacylhydroxylamine bleach activators and compositions employing the same
09/06/2000EP1032560A1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate
09/06/2000EP1032556A1 Pharmaceutically active compounds and methods of use
09/06/2000EP1032555A1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
09/06/2000EP1032424A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor
09/06/2000EP1032385A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cellproliferation, diarrhe and scours
09/06/2000EP0824514B1 Dihalopropene compounds, insecticides containing them as active ingredients, and intermediates for their production
09/06/2000CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4
09/06/2000CN1265660A 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives
09/06/2000CN1265654A 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring
09/06/2000CN1265652A 2-acrylaminopropanamines as tachykinin receptor antagonists
09/06/2000CN1265651A Novel tircyclic compounds having saturated rings and medicinalcompositions containing the same
09/06/2000CN1265650A Special 3-azabicyclo [3,1,0] hexanes, method for producing and modifying the same, and their use
09/06/2000CN1265649A Indole derivatives as MCP-1 receptor antagonists
09/06/2000CN1265647A Acrylic metalloprotease inhibitor
09/06/2000CN1265645A Urokinase inhibitors
09/06/2000CN1265591A Coumpound
09/06/2000CN1265590A Substituted alkanohydroxamic acid and method of reducing TNF 'alpha' levels
09/06/2000CN1056144C New use of 6-heterocyclic-4-amino-3,4,5-tetrahydrobenz (CD) indoles compound
09/05/2000US6114536 Indolin-2-one derivatives
09/05/2000US6114532 Anticoagulant
09/05/2000US6114531 Reacting 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8 -naphthyridine-3-carboxylic acid with a fused aminoaromatic salt to from trovafloxacin
09/05/2000US6114529 Useful for preparing camptothecin derivatives having antitumor activities
09/05/2000US6114419 Fluorinated imides useful to impart repellency of low surface tension fluids to nonwoven fabrics, fibers, films and fabrics; melt extruding a filament of a dispersion of polymers and heterocyclic imide; molding materials
09/05/2000US6114393 Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoa
09/05/2000US6114390 An argininamide or ornithinamide compound as treating memory loss, migraine, sleep disorders, pain, cardiovascular diseases, subarachnoidal bleeding, vascular-hypertrophic changes, cerebral and coronary vasospasms
09/05/2000US6114386 1-((substituted)alkylcarbonylamino),2-(hydroxyl or amino)-substituted benzene compounds of given formula; treating and preventing bacterial or trypanosomal infection using the inhibitor
09/05/2000US6114381 To control brain damage associated with anoxia or ischemia which typically follows stroke, cardiac arrest or perinatal asphyxia; compound is an antagonist to inhibit excitotoxic actions at excitatory amino acid receptor sites
09/05/2000US6114374 2-and 2,5-substituted phenylketoenols
09/05/2000US6114373 N-acetyl-5,6-dimethoxytryptamine and its free radical scavenging activity